Global Pharmaceutical Decommissioning Service Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI08256731

Publication Date:

August 11, 2025

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

According to this study, the global Pharmaceutical Decommissioning Service market size will reach US$ 1102 million by 2031.
Pharmaceutical Decommissioning Service is a one-stop professional service from assessment, planning, demolition, disposal to site restoration and reuse for production facilities, equipment, plants and related systems that are decommissioned by pharmaceutical companies due to equipment aging, technology upgrades, regulatory requirements or corporate strategy adjustments. It covers equipment compliance inspection, hazardous substance treatment, waste environmental recycling, safe demolition of building structures and site ecological restoration, ensuring that the decommissioning process complies with the Good Manufacturing Practice (GMP) for pharmaceuticals, environmental protection regulations and safety production standards. At the same time, through resource recycling and site function reconstruction, it helps companies achieve sustainable development goals.
United States market for Pharmaceutical Decommissioning Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pharmaceutical Decommissioning Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pharmaceutical Decommissioning Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pharmaceutical Decommissioning Service players cover KDC Veolia, RCS Pharma, Technical Safety Services, ISPE, Brilliant Equipment Services, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧harmaceutical Decommissioning Service Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical Decommissioning Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Decommissioning Service sales for 2025 through 2031. With Pharmaceutical Decommissioning Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Decommissioning Service industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Decommissioning Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Decommissioning Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical Decommissioning Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Decommissioning Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Decommissioning Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Decommissioning Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Equipment Decommissioning Service
Facility Decommissioning Service
Laboratory Decommissioning Service
Others
Segmentation by Application:
Pharmaceutical Manufacturers
Pharmaceutical CDMO
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
KDC Veolia
RCS Pharma
Technical Safety Services
ISPE
Brilliant Equipment Services
Qualitech Environmental Services
Hughes & Salvidge
Divestiture
Pharmagraph
RVA Group
DSM Demolition
KERAMIDA Inc
Downwell Enabling Solutions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Decommissioning Service Market Size (2020-2031)
2.1.2 Pharmaceutical Decommissioning Service Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmaceutical Decommissioning Service by Country/Region (2020, 2024 & 2031)
2.2 Pharmaceutical Decommissioning Service Segment by Type
2.2.1 Equipment Decommissioning Service
2.2.2 Facility Decommissioning Service
2.2.3 Laboratory Decommissioning Service
2.2.4 Others
2.3 Pharmaceutical Decommissioning Service Market Size by Type
2.3.1 Pharmaceutical Decommissioning Service Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmaceutical Decommissioning Service Market Size Market Share by Type (2020-2025)
2.4 Pharmaceutical Decommissioning Service Segment by Application
2.4.1 Pharmaceutical Manufacturers
2.4.2 Pharmaceutical CDMO
2.5 Pharmaceutical Decommissioning Service Market Size by Application
2.5.1 Pharmaceutical Decommissioning Service Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmaceutical Decommissioning Service Market Size Market Share by Application (2020-2025)
3 Pharmaceutical Decommissioning Service Market Size by Player
3.1 Pharmaceutical Decommissioning Service Market Size Market Share by Player
3.1.1 Global Pharmaceutical Decommissioning Service Revenue by Player (2020-2025)
3.1.2 Global Pharmaceutical Decommissioning Service Revenue Market Share by Player (2020-2025)
3.2 Global Pharmaceutical Decommissioning Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Decommissioning Service by Region
4.1 Pharmaceutical Decommissioning Service Market Size by Region (2020-2025)
4.2 Global Pharmaceutical Decommissioning Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Decommissioning Service Market Size Growth (2020-2025)
4.4 APAC Pharmaceutical Decommissioning Service Market Size Growth (2020-2025)
4.5 Europe Pharmaceutical Decommissioning Service Market Size Growth (2020-2025)
4.6 Middle East & Africa Pharmaceutical Decommissioning Service Market Size Growth (2020-2025)
5 Americas
5.1 Americas Pharmaceutical Decommissioning Service Market Size by Country (2020-2025)
5.2 Americas Pharmaceutical Decommissioning Service Market Size by Type (2020-2025)
5.3 Americas Pharmaceutical Decommissioning Service Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Decommissioning Service Market Size by Region (2020-2025)
6.2 APAC Pharmaceutical Decommissioning Service Market Size by Type (2020-2025)
6.3 APAC Pharmaceutical Decommissioning Service Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Decommissioning Service Market Size by Country (2020-2025)
7.2 Europe Pharmaceutical Decommissioning Service Market Size by Type (2020-2025)
7.3 Europe Pharmaceutical Decommissioning Service Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Decommissioning Service by Region (2020-2025)
8.2 Middle East & Africa Pharmaceutical Decommissioning Service Market Size by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Decommissioning Service Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Decommissioning Service Market Forecast
10.1 Global Pharmaceutical Decommissioning Service Forecast by Region (2026-2031)
10.1.1 Global Pharmaceutical Decommissioning Service Forecast by Region (2026-2031)
10.1.2 Americas Pharmaceutical Decommissioning Service Forecast
10.1.3 APAC Pharmaceutical Decommissioning Service Forecast
10.1.4 Europe Pharmaceutical Decommissioning Service Forecast
10.1.5 Middle East & Africa Pharmaceutical Decommissioning Service Forecast
10.2 Americas Pharmaceutical Decommissioning Service Forecast by Country (2026-2031)
10.2.1 United States Market Pharmaceutical Decommissioning Service Forecast
10.2.2 Canada Market Pharmaceutical Decommissioning Service Forecast
10.2.3 Mexico Market Pharmaceutical Decommissioning Service Forecast
10.2.4 Brazil Market Pharmaceutical Decommissioning Service Forecast
10.3 APAC Pharmaceutical Decommissioning Service Forecast by Region (2026-2031)
10.3.1 China Pharmaceutical Decommissioning Service Market Forecast
10.3.2 Japan Market Pharmaceutical Decommissioning Service Forecast
10.3.3 Korea Market Pharmaceutical Decommissioning Service Forecast
10.3.4 Southeast Asia Market Pharmaceutical Decommissioning Service Forecast
10.3.5 India Market Pharmaceutical Decommissioning Service Forecast
10.3.6 Australia Market Pharmaceutical Decommissioning Service Forecast
10.4 Europe Pharmaceutical Decommissioning Service Forecast by Country (2026-2031)
10.4.1 Germany Market Pharmaceutical Decommissioning Service Forecast
10.4.2 France Market Pharmaceutical Decommissioning Service Forecast
10.4.3 UK Market Pharmaceutical Decommissioning Service Forecast
10.4.4 Italy Market Pharmaceutical Decommissioning Service Forecast
10.4.5 Russia Market Pharmaceutical Decommissioning Service Forecast
10.5 Middle East & Africa Pharmaceutical Decommissioning Service Forecast by Region (2026-2031)
10.5.1 Egypt Market Pharmaceutical Decommissioning Service Forecast
10.5.2 South Africa Market Pharmaceutical Decommissioning Service Forecast
10.5.3 Israel Market Pharmaceutical Decommissioning Service Forecast
10.5.4 Turkey Market Pharmaceutical Decommissioning Service Forecast
10.6 Global Pharmaceutical Decommissioning Service Forecast by Type (2026-2031)
10.7 Global Pharmaceutical Decommissioning Service Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Pharmaceutical Decommissioning Service Forecast
11 Key Players Analysis
11.1 KDC Veolia
11.1.1 KDC Veolia Company Information
11.1.2 KDC Veolia Pharmaceutical Decommissioning Service Product Offered
11.1.3 KDC Veolia Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 KDC Veolia Main Business Overview
11.1.5 KDC Veolia Latest Developments
11.2 RCS Pharma
11.2.1 RCS Pharma Company Information
11.2.2 RCS Pharma Pharmaceutical Decommissioning Service Product Offered
11.2.3 RCS Pharma Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 RCS Pharma Main Business Overview
11.2.5 RCS Pharma Latest Developments
11.3 Technical Safety Services
11.3.1 Technical Safety Services Company Information
11.3.2 Technical Safety Services Pharmaceutical Decommissioning Service Product Offered
11.3.3 Technical Safety Services Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Technical Safety Services Main Business Overview
11.3.5 Technical Safety Services Latest Developments
11.4 ISPE
11.4.1 ISPE Company Information
11.4.2 ISPE Pharmaceutical Decommissioning Service Product Offered
11.4.3 ISPE Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ISPE Main Business Overview
11.4.5 ISPE Latest Developments
11.5 Brilliant Equipment Services
11.5.1 Brilliant Equipment Services Company Information
11.5.2 Brilliant Equipment Services Pharmaceutical Decommissioning Service Product Offered
11.5.3 Brilliant Equipment Services Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Brilliant Equipment Services Main Business Overview
11.5.5 Brilliant Equipment Services Latest Developments
11.6 Qualitech Environmental Services
11.6.1 Qualitech Environmental Services Company Information
11.6.2 Qualitech Environmental Services Pharmaceutical Decommissioning Service Product Offered
11.6.3 Qualitech Environmental Services Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Qualitech Environmental Services Main Business Overview
11.6.5 Qualitech Environmental Services Latest Developments
11.7 Hughes & Salvidge
11.7.1 Hughes & Salvidge Company Information
11.7.2 Hughes & Salvidge Pharmaceutical Decommissioning Service Product Offered
11.7.3 Hughes & Salvidge Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Hughes & Salvidge Main Business Overview
11.7.5 Hughes & Salvidge Latest Developments
11.8 Divestiture
11.8.1 Divestiture Company Information
11.8.2 Divestiture Pharmaceutical Decommissioning Service Product Offered
11.8.3 Divestiture Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Divestiture Main Business Overview
11.8.5 Divestiture Latest Developments
11.9 Pharmagraph
11.9.1 Pharmagraph Company Information
11.9.2 Pharmagraph Pharmaceutical Decommissioning Service Product Offered
11.9.3 Pharmagraph Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Pharmagraph Main Business Overview
11.9.5 Pharmagraph Latest Developments
11.10 RVA Group
11.10.1 RVA Group Company Information
11.10.2 RVA Group Pharmaceutical Decommissioning Service Product Offered
11.10.3 RVA Group Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 RVA Group Main Business Overview
11.10.5 RVA Group Latest Developments
11.11 DSM Demolition
11.11.1 DSM Demolition Company Information
11.11.2 DSM Demolition Pharmaceutical Decommissioning Service Product Offered
11.11.3 DSM Demolition Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 DSM Demolition Main Business Overview
11.11.5 DSM Demolition Latest Developments
11.12 KERAMIDA Inc
11.12.1 KERAMIDA Inc Company Information
11.12.2 KERAMIDA Inc Pharmaceutical Decommissioning Service Product Offered
11.12.3 KERAMIDA Inc Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 KERAMIDA Inc Main Business Overview
11.12.5 KERAMIDA Inc Latest Developments
11.13 Downwell Enabling Solutions
11.13.1 Downwell Enabling Solutions Company Information
11.13.2 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Product Offered
11.13.3 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Downwell Enabling Solutions Main Business Overview
11.13.5 Downwell Enabling Solutions Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂